Importantly, knockdown of MAP3K1 alone effectively attenuated cardiac hypertrophy to a similar extent as the drug combination, suggesting its role as a critical mediator through which Sal B and Sen I exert their therapeutic effects. The gene discussed is MAP3K1; the disease is cardiac hypertrophy.